Analyst Price Targets — SVRA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 16, 2026 3:22 pm | — | William Blair | $10.00 | $5.17 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Savara (SVRA): 'well positioned ahead of the August PDUFA date' |
| December 23, 2025 11:42 am | — | Oppenheimer | $10.00 | $6.47 | StreetInsider | Savara (SVRA) PT Raised to $10 at H.C. Wainwright |
| December 23, 2025 11:42 am | — | UBS | $10.00 | $6.47 | StreetInsider | Savara (SVRA) PT Raised to $10 at H.C. Wainwright |
| October 23, 2025 8:42 am | — | JMP Securities | $11.00 | $4.24 | TheFly | Savara price target raised to $11 from $8 at Citizens JMP |
| September 9, 2025 11:07 am | — | Guggenheim | $11.00 | $3.82 | TheFly | Savara price target raised to $11 from $8 at Guggenheim |
| August 15, 2025 1:07 pm | Andrew Fein | H.C. Wainwright | $5.00 | $3.09 | TheFly | H.C. Wainwright upgrades Savara to Buy on resubmission prospects |
| August 13, 2024 6:01 am | Jonathan Wolleben | JMP Securities | $4.50 | $2.04 | TheFly | Savara price target lowered to $9 from $10 at JMP Securities |
| June 27, 2024 8:56 am | Vamil Divan | Guggenheim | $5.00 | $1.92 | TheFly | Savara price target raised to $10 from $8 at Guggenheim |
| June 27, 2024 6:03 am | Andrew Fein | H.C. Wainwright | $5.00 | $1.92 | TheFly | Savara price target raised to $10 from $6 at H.C. Wainwright |
| June 27, 2024 5:38 am | Jonathan Wolleben | JMP Securities | $5.00 | $1.98 | StreetInsider | Savara (SVRA) PT Raised to $10 at JMP Securities |
Latest News for SVRA
BlackRock Inc. acquired a new position in Savara Inc. (NASDAQ: SVRA) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,494,498 shares of the company's stock, valued at approximately $76,966,000. BlackRock Inc. owned approximately 6.10% of Savara at the end of
Algert Global LLC boosted its position in Savara Inc. (NASDAQ: SVRA) by 53.7% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,329,259 shares of the company's stock after purchasing an additional 464,645 shares during the quarter. Algert Global LLC
Deutsche Bank AG purchased a new position in Savara Inc. (NASDAQ: SVRA) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 864,956 shares of the company's stock, valued at approximately $5,328,000. Deutsche Bank AG owned about 0.42% of Savara as of its
YARDLEY, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the acceptance of one oral presentation and two poster presentations on data from the Phase 3 IMPALA-2 clinical trial at the ERS Congress in Barcelona, Spain, September 5-9, 2026.“Collectively, these data show that molgramostim continues to improve lung function,…
YARDLEY, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to new employees. On August 17, 2026, the Compensation Committee of Savara's Board of Directors granted the inducement awards to eight new employees who recently joined the Company. The inducement awards consist of options to…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SVRA.
U.S. House Trading
No House trades found for SVRA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.